SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-068425
Filing Date
2014-11-14
Accepted
2014-11-14 12:15:07
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v393135_10q.htm 10-Q 351835
2 EXHIBIT 31.1 v393135_ex31-1.htm EX-31.1 9627
3 EXHIBIT 31.2 v393135_ex31-2.htm EX-31.2 8726
4 EXHIBIT 32.1 v393135_ex32-1.htm EX-32.1 4624
  Complete submission text file 0001144204-14-068425.txt   3407103

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mtnb-20140930.xml EX-101.INS 463546
6 XBRL TAXONOMY EXTENSION SCHEMA mtnb-20140930.xsd EX-101.SCH 38582
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mtnb-20140930_cal.xml EX-101.CAL 25514
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mtnb-20140930_def.xml EX-101.DEF 196472
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtnb-20140930_lab.xml EX-101.LAB 204556
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtnb-20140930_pre.xml EX-101.PRE 229439
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-193455 | Film No.: 141222004
SIC: 2834 Pharmaceutical Preparations